Figure 4.
Plots of estimated HRs of overall VTE and unprovoked VTE as a function of maximum time from blood sampling in HUNT 3 (2006-2008) to thrombotic events. (A) Overall VTE; (B) unprovoked VTE. All analyses were adjusted for age, sex, BMI, and cancer and arterial CVD at baseline. Participants with plasma expression levels of miR-145 in the highest quartile (Q4) were compared with those with miR-145 in the lowest quartile (Q1, reference category). Large, solid blue circles indicate HRs with P < .05. The number of VTE events in the analysis for a given maximum (max) study time are depicted above the plot.